Virtual Clinical Trials: Feasibility For Ophthalmic Endpoints (BCVA, OCT, IOP)

Virtual clinical trials are transforming ophthalmology research by enabling remote collection of key endpoints such as best-corrected visual acuity (BCVA), optical coherence tomography (OCT), and intraocular pressure (IOP). These capabilities help overcome persistent challenges in patient recruitment, retention, and site workload. By integrating mobile clinics, connected diagnostic devices, and telehealth platforms, researchers can capture reliable, high-quality ophthalmic data while significantly improving accessibility for patients across diverse geographic and socioeconomic backgrounds.

This decentralized approach also supports stronger patient engagement, as participants can complete assessments with far greater convenience and fewer site visits. At the same time, sponsors and CROs benefit from a more scalable and cost-efficient model that preserves scientific rigor, maintains regulatory compliance, and accelerates overall study timelines. The ability to collect precise ophthalmic measurements outside brick-and-mortar sites represents a meaningful shift toward more flexible, patient-centric research designs.

Explore how decentralized strategies are reshaping the future of ophthalmic studies and the operational considerations — from technology selection to workflow integration — that ensure successful implementation. Access the full resource to learn practical steps for adopting virtual endpoints in your ophthalmology trials.